CLINICAL ROLE -
Notable Revisions in Diabetes Treatment According to ADA Guidelines
American Diabetes Association updates recommendations regarding SGLT-2 inhibitors, GLP-1 RA, and finerenone for cardiovascular and renal comorbidities.
Read More